Christopher Zi Qian Choo, Joey Yun Xuan Ching, Myra Mazhar Ud Deen, Zhi Yuan Kok
{"title":"Small-molecule fluorescent probes for the aminergic GPCRs – What new tool compounds do we have post-2014 and what can they do?","authors":"Christopher Zi Qian Choo, Joey Yun Xuan Ching, Myra Mazhar Ud Deen, Zhi Yuan Kok","doi":"10.1016/j.ejmech.2026.118579","DOIUrl":null,"url":null,"abstract":"<div><div>Aminergic G protein-coupled receptors (GPCRs) are heavily involved in the physiological functions of the human body and represent prominent drug targets for numerous diseases. Despite extensive work over the years, knowledge gaps persist as not all aminergic GPCRs are currently drugged. This gap could be addressed by using small-molecule fluorescent probes across a range of assay formats and experiments to obtain deeper insights into the molecular pharmacology of these receptors. This review highlights key developments from 2014 to 2024 in the design and application of fluorescent probes targeting aminergic GPCRs, featuring a total of 36 fluorescent probes spanning all prominent aminergic GPCR subfamilies: adrenergic, dopaminergic, histaminergic, muscarinic, and serotonergic receptors. This review provides a detailed overview of the approaches to probe design, their pharmacological profiles and their reported utilities in ligand binding assays and imaging studies. In recent years, these applications have expanded to include <em>ex vivo</em> and <em>in vivo</em> studies in both mice and human tissue models. With the integration of cutting-edge image processing and artificial intelligence-driven image recognition technologies, fluorescent probes will remain indispensable tools for investigating the molecular pharmacology of aminergic GPCRs, playing a crucial role in driving forward drug discovery in this field.</div></div>","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"305 ","pages":"Article 118579"},"PeriodicalIF":5.9000,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0223523426000243","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aminergic G protein-coupled receptors (GPCRs) are heavily involved in the physiological functions of the human body and represent prominent drug targets for numerous diseases. Despite extensive work over the years, knowledge gaps persist as not all aminergic GPCRs are currently drugged. This gap could be addressed by using small-molecule fluorescent probes across a range of assay formats and experiments to obtain deeper insights into the molecular pharmacology of these receptors. This review highlights key developments from 2014 to 2024 in the design and application of fluorescent probes targeting aminergic GPCRs, featuring a total of 36 fluorescent probes spanning all prominent aminergic GPCR subfamilies: adrenergic, dopaminergic, histaminergic, muscarinic, and serotonergic receptors. This review provides a detailed overview of the approaches to probe design, their pharmacological profiles and their reported utilities in ligand binding assays and imaging studies. In recent years, these applications have expanded to include ex vivo and in vivo studies in both mice and human tissue models. With the integration of cutting-edge image processing and artificial intelligence-driven image recognition technologies, fluorescent probes will remain indispensable tools for investigating the molecular pharmacology of aminergic GPCRs, playing a crucial role in driving forward drug discovery in this field.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.